✦ LIBER ✦

EGFR Function and Detection in Cancer Therapy

✍ Scribed by John Fruehauf

Publisher: John Wiley and Sons
Year: 2006
Weight: 8 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200645277

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.

📜 SIMILAR VOLUMES

EGFR-Targeted Therapies in Colorectal Ca

EGFR-Targeted Therapies in Colorectal Cancer

✍ Michael J. Overman; Paulo M. Hoff 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 376 KB

Chemohormonal therapy and endocrine func

Chemohormonal therapy and endocrine function in breast cancer patients

✍ Ann M. Dnistrian; Ernest J. Greenberg; Hildy J. Dillon; Thomas B. Hakes; Alfred 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 682 KB

STAT-mediated EGFR signaling in cancer

✍ Kelly M. Quesnelle; Amanda L. Boehm; Jennifer R. Grandis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

## Abstract The epidermal growth factor receptor (EGFR) and signal transducers and activators of transcription (STATs) are commonly expressed and activated in many malignancies. EGFR is an upstream activator of several pathways involved in tumor progression, and STATs activate selected genes involv

EGFR Signaling Networks in Cancer Therap

EGFR Signaling Networks in Cancer Therapy. Edited by John D. Haley and William J. Gullick.

✍ Adriano Martinelli 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

TGF-α and EGFR in head and neck cancer

✍ Jennifer R. Grandis; David J. Tweardy 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

The upper aerodigestive tract mucosa of patients who develop squamous cell carcinoma of the head and neck (SCCHN) is predisposed to abnormally regulated growth, evidenced by the high incidence of synchronous and metachronous malignancies. We conducted a series of experiments to show that aberrant re

EGFR mutations are detected comparably i

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

✍ Jason H. Smouse; Edmund S. Cibas; Pasi A. Jänne; Victoria A. Joshi; Kelly H. Zou 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 233 KB

## Abstract ## BACKGROUND: Somatic mutations in the epidermal growth factor receptor (__EGFR__) are present in ∼10% of nonsmall cell lung cancers, and higher in never‐smokers, women, and Asians. Small in‐frame deletions in exon 19 (∼45%) and L858R mutation in exon 21 (∼40%) predict response to tre